Breaking

Who am I? Plus today's other quizzes Roast chicken, congee and cookies: Ravinder Bhogal’s autumn squash recipes LIV Golf secures potential $300m investment Nobel prize in physics goes to Francis Halzen for south pole work on neutrinos Gassiev unsure if Fury v Joshua will be for his WBA belt Stop worrying about my AI, says multibillionaire Sam Altman. So we bear the risks and he keeps the money | Chris Stokel-Walker Cristiano Ronaldo accuses Portugal coach Jorge Jesus of broken promises How AI decision models could change content moderation Republican John James seeks some distance from Trump in Michigan governor debate Battle of ideas looming in British politics, Badenoch to say

NEWSREEL

The day, in 30-second reels.

--:--:--

Business / Reel

Business · Video brief

AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

AstraZeneca is negotiating a potential merger with Bristol Myers Squibb, aiming to form a pharmaceutical powerhouse valued at $400 billion. However, AstraZeneca's shares have fallen by over 7% during these discussions. If the merger succeed...

The Guardian· Aug 3, 2026 · 10:20 AM · 206 views

Video won't play? Watch on YouTube →

AstraZeneca is negotiating a potential merger with Bristol Myers Squibb, aiming to form a pharmaceutical powerhouse valued at $400 billion. However, AstraZeneca's shares have fallen by over 7% during these discussions. If the merger succeeds, it could significantly impact the oncology market.

Full story and more reels: https://newsreel.video

#news #breaking #pharma #mergers #AstraZeneca #BristolMyersSquibb

Originally reported by The Guardian. Read the full story →

More in Business

Poland’s ‘solidarity’ push for EU energy resilience in face of Russian aggression

The Guardian· 7 hours ago

Georgia governor candidates spar over the economy and Trump in lone debate

NBC News· 8 hours ago

Ukraine war briefing: Kyiv claims half of Russia’s oil refining capacity destroyed

The Guardian· 10 hours ago

0 Comments

No comments yet. Be the first.